Moolec Science (MLEC) Interest Expenses (2022 - 2024)
Moolec Science's (MLEC) quarterly Interest Expenses came in at -$664020.0 in Q4 2024, down 542.25% year-on-year from $150146.6 in Q1 2024, and down 20.69% quarter-over-quarter from -$550170.0 in Q3 2024.
Moolec Science (MLEC) Interest Expenses (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Interest Expenses across 3 years of filings, most recently posting -$664020.0 for Q4 2024.
- Interest Expenses for Q4 2024 came in at -$664020.0, down 542.25% year-over-year; the trailing twelve-month figure through Mar 2026 was -$664020.0 (changed N/A YoY), and the FY2024 annual result was -$37.5 million, down 11.68% from the prior year.
- Interest Expenses came in at -$664020.0 for Q4 2024 at Moolec Science, down from -$550170.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of -$99419.0 in Q3 2023 to a low of -$37.5 million in Q2 2024.
- The 3-year median for Interest Expenses is -$607095.0 (2024), against an average of -$12.0 million.
- Peak annual rise in Interest Expenses reached 11.68% in 2024, while the deepest fall reached 542.25% in 2024.
- Moolec Science's Interest Expenses stood at -$22.8 million in 2022, then jumped by 99.55% to -$103390.0 in 2023, then plunged by 542.25% to -$664020.0 in 2024.
- The last three Interest Expenses figures came in at -$664020.0 (Q4 2024), -$550170.0 (Q3 2024), and -$37.5 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -5.58 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -664,020.00 |
| Dec 31, 2024 | -664,020.00 |
| Sep 30, 2024 | -550,170.00 |
| Sep 30, 2024 | -550,170.00 |
| Jun 30, 2024 | -37.50 Mn |
| Jun 30, 2024 | -37.50 Mn |
| Mar 31, 2024 | -358,828.00 |
| Mar 31, 2024 | -358,828.00 |
| Dec 31, 2023 | -103,390.00 |
| Dec 31, 2023 | -103,390.00 |
| Sep 30, 2023 | -99,419.00 |
| Sep 30, 2023 | -99,419.00 |
| Jun 30, 2023 | -33.58 Mn |
| Jun 30, 2023 | -33.58 Mn |
| Jun 30, 2022 | -22.76 Mn |
| Jun 30, 2022 | -22.76 Mn |